Imaging in Stem Cell Transplant and Cell-based Therapy

14

stem cells have been studied using this approach including myocardial stem cell
(Fig. 1.4) [ 32 ], pancreatic islet cells [ 33 ], Thyroid and other organs (using a sodium
iodide symporter reporter gene) [ 33 ].

1.4 Conclusion

Stem cell transplant techniques are making rapid strides in clinical and research
applications especially in newer non-hematological applications. Radiologists have
a key role to play in this area as imaging experts and interventionists.

References

1. Pandey T, Thomas S, Heller MT. Current indications, techniques, and imaging findings of stem
   cell treatment and bone marrow transplant. Radiol Clin North Am (Elsevier). 2016;54(2).


2. Nikolic B, Faintuch S, Goldberg SN, Kuo MD, Cardella JF. Stem cell therapy: a primer for
   interventionalists and imagers. J Vasc Interv Radiol. 2009;20(8):999–1012.


3. BE, Tuch. "Stem cells–a clinical update.." Aust Fam Physician 35, no. 9 (Sep 2006): 719–721.


4. Thomas ED, Blume KG. Historical markers in the development of allogeneic hematopoietic
   cell transplantation. Biol Blood Marrow Transplant. 1999;5(6):341–6.


5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones
   JM, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;1145–7.


6. Shostak S. (Re)defining stem cells. BioEssays. 2006;28(3):301–8.


7. Coppi PD.  Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol.
   2007;25(1):100–6.


8. Gratwohl A, Baldomero H, Aljurf M, et al. Hematopoietic stem cell transplantation: a global
   perspective. JAMA. 2010;303(16):1617–24.


9. Hugle T, van Laar JM. Stem cell transplantation for rheumatic autoimmune diseases. Arthritis
   Res Ther. 2008;10(5):217.


10. Mascarenhas S, Avalos B, Ardoin SP. An update on stem cell transplantation in autoimmune
    rheumatologic disorders. Curr Allergy Asthma Rep. 2012;12(6):530–40.


11. Sullivan KM, Muraro P, Tyndall A.  Hematopoietic cell transplantation for autoimmune dis-
    ease: updates from Europe and the United States. Biol Blood Marrow Transplant.
    2010;16(1):S48–56.


12. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic
    heart disease: promise, uncertainties, and challenges. Eur Heart J. 2011;32(10):1197–206.


13. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction
    of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):
    861–72.


14. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M. Increased knee cartilage volume in
    degenerative joint disease using percutaneously implanted, autologous mesenchymal stem
    cells. Pain Physician. 2008;11(3). (2008):343–53.


15. Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Yin Z, Li H, Zhang Y, Diao Y, Li Y, Chen Y, Sun X, Fisk
    MB, Skidgel R, Holterman M, Prabhakar B, Mazzone T. Reversal of type 1 diabetes via islet ß
    cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
    BMC Med. 2012;10:1–11.

T. Pa ndey